Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $2.454B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $772M | 31.5% | — | — | CLASS A ORD | 61559X104 |
| AXSM | AXSOME THERAPEUTICS INC | 1,690,221 | $197M | 8.0% | — | — | COM | 05464T104 |
| RVMD | REVOLUTION MEDICINES INC | 4,982,384 | $176M | 7.2% | — | — | COM | 76155X100 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $141M | 5.8% | — | — | COM | 501575104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,796,513 | $126M | 5.1% | — | — | COM | 604749101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,575,015 | $125M | 5.1% | — | — | COM | 74366E102 |
| GHRS | GH RESEARCH PLC | 8,827,712 | $97.37M | 4.0% | — | — | ORDINARY SHARES | G3855L106 |
| XOMA | XOMA ROYALTY CORPORATION | 2,983,026 | $59.45M | 2.4% | — | — | COM NEW | 98419J206 |
| IONS | IONIS PHARMACEUTICALS INC | 1,913,385 | $57.73M | 2.4% | — | — | COM | 462222100 |
| ZYME | ZYMEWORKS INC | 4,308,935 | $51.32M | 2.1% | — | — | COM | 98985Y108 |
| KURA | KURA ONCOLOGY INC | 7,754,129 | $51.18M | 2.1% | — | — | COM | 50127T109 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $43.53M | 1.8% | — | — | COM | 230031106 |
| ACIU | AC IMMUNE SA | 19,822,436 | $37.07M | 1.5% | — | — | SHS | H00263105 |
| TYRA | TYRA BIOSCIENCES INC | 3,944,194 | $36.68M | 1.5% | — | — | COM | 90240B106 |
| GLPG | GALAPAGOS NV | 1,454,422 | $36.54M | 1.5% | — | — | SPON ADR | 36315X101 |
| CELC | CELCUITY INC | 3,466,000 | $35.04M | 1.4% | — | — | COM | 15102K100 |
| — | VERVE THERAPEUTICS INC | 6,904,050 | $31.55M | 1.3% | — | — | COM | 92539P101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,771,417 | $30.66M | 1.2% | — | — | SPONSORED ADS | 86366E106 |
| XNCR | XENCOR INC | 2,740,141 | $29.16M | 1.2% | — | — | COM | 98401F105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 5,660,132 | $26.26M | 1.1% | — | — | COM | 61225M102 |
| SEPN | SEPTERNA INC | 4,396,124 | $25.45M | 1.0% | — | — | COM | 81734D104 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $21.33M | 0.9% | — | — | COM | 28617K101 |
| — | CIDARA THERAPEUTICS INC | 924,642 | $19.92M | 0.8% | — | — | COM NEW | 171757206 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $19.91M | 0.8% | — | — | COM | 68062P106 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 696,555 | $19.5M | 0.8% | — | — | COM | 697947109 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $19.35M | 0.8% | — | — | COM | 344174107 |
| — | ITEOS THERAPEUTICS INC | 3,075,000 | $18.36M | 0.7% | — | — | COM | 46565G104 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,561,289 | $14.73M | 0.6% | — | — | COM | 35104E100 |
| — | ESSA PHARMA INC | 8,748,629 | $13.82M | 0.6% | — | — | COM NEW | 29668H708 |
| ANNX | ANNEXON INC | 7,000,000 | $13.51M | 0.6% | — | — | COM | 03589W102 |
| VSTM | VERASTEM INC | 2,100,468 | $12.67M | 0.5% | — | — | COM NEW | 92337C203 |
| — | RAPT THERAPEUTICS INC | 9,237,556 | $11.27M | 0.5% | — | — | COM | 75382E109 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $10.19M | 0.4% | — | — | COM | 760273102 |
| IMUX | IMMUNIC INC | 8,902,972 | $9.704M | 0.4% | — | — | COM | 4525EP101 |
| AVTX | AVALO THERAPEUTICS INC | 1,036,679 | $8.304M | 0.3% | — | — | COM NEW | 05338F306 |
| — | THIRD HARMONIC BIO INC | 2,372,933 | $8.234M | 0.3% | — | — | COM | 88427A107 |
| — | VIGIL NEUROSCIENCE INC | 4,013,633 | $7.144M | 0.3% | — | — | COM | 92673K108 |
| TCRX | TSCAN THERAPEUTICS INC | 4,889,474 | $6.747M | 0.3% | — | — | COM | 89854M101 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5.511M | 0.2% | — | — | ADS | 60853G106 |
| — | IKENA ONCOLOGY INC | 4,006,564 | $5.128M | 0.2% | — | — | COM | 45175G108 |
| FBRX | FORTE BIOSCIENCES INC | 594,282 | $4.612M | 0.2% | — | — | COM NEW | 34962G208 |
| — | ALLAKOS INC | 16,552,417 | $3.767M | 0.2% | — | — | COM | 01671P100 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $3.324M | 0.1% | — | — | COM | 23284F105 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $2.224M | 0.1% | — | — | COM NEW | 88032L605 |
| IVA | INVENTIVA SA | 686,040 | $2.058M | 0.1% | — | — | ADS | 46124U107 |
| — | GLYCOMIMETICS INC | 9,544,262 | $2.004M | 0.1% | — | — | COM | 38000Q102 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $1.239M | 0.1% | — | — | COM NEW | 78397T202 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 59,065 | $1.209M | 0.0% | — | — | ORDINARY SHARES | N62509109 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $1.202M | 0.0% | — | — | COM | 690469101 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $605K | 0.0% | — | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $221K | 0.0% | — | — | COM NEW | H57830137 |